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Previous  investigations  have  shown  that  carcinomas  of  the  human  colon 
contain  a  tumor-associated antigen  (1).  Antisera prepared against  extracts of 
colon carcinoma demonstrated  an  antigen(s)  present in  all  colon carcinomas, 
but absent from, or present at very low levels in, corresponding normal colonic 
tissue  (2-4).  The  antigen  was  also  identified  in  embryonic and  fetal gastro- 
intestinal tissues, and because of this, the material was designated the carcino- 
embryonic antigen (CEA)  1 of the human digestive system (2). 
Preliminary characterization of the antigenic material extracted and partially 
purified from tumor tissue indicated that it was a  glycoprotein (5). It  seems 
important to characterize these extracts further, and for this reason,  chemical 
studies  of preparations with CEA  activity are being carried out. This report 
describes preliminary results of amino acid sequence studies of the only protein 
in these preparations with an unblocked amino-terminal  amino acid. 
Materials and Methods 
Colon cancer metastases were obtained from the livers of patients Be and Nai at autopsy 
and frozen at  --10°C until used. A complete description of the isolation procedure used is 
presented elsewhere (3). In brief,  tumor tissue was homogenized in a Waring blender (Waring 
Products Div., New Hartford, Conn.) and mixed with an equal volume of 2 ~ perchloric acid. 
The precipitate was removed by centrifugation, and  the supernatant chromatographed on 
Sepharose 4B  (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.). Fractions containing CEA 
activity, as detected by a double antibody assay (6), were pooled and rechromatographed on a 
column of Sephadex G-200  (Pharmacia). Active fractions were pooled and lyophilized. 
The Na  1 preparation was further purified by  chromatography on epichlorohydrin tri- 
ethanolamine cellulose brought to a  pH of 6.5 and equilibrated with 0.01 m: NaC1. Samples 
were applied in 0.01 ~ NaC1 and eluted using an exponential gradient with a final concentra- 
tion of 0.2 ~t NaCI. Multiple peaks were obtained and all contained CEA antigenic activity. 
* This work was supported in part by grant No. 12631 from the National Cancer Institute. 
1  Abbreviations ~¢sed in this paper: CEA, carcinoembryonic antigen; SDS,  sodium dodecyl 
sulfate. 
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One portion of the column effluent designated Na 1-3 was chosen for further chemical char- 
acterization. 
RESULTS AND  DISCUSSION 
Isolated Be material was studied by disc gel electrophoresis in 4  % acrylamide 
gels with or without urea at pH 8.7 (7), and sodium  dodecyl  sulfate (SDS) gels 
containing 3.3 % aerylamide (8). Gels stained for periodate oxidizable sugars 
(9) revealed a single diffuse band, with no discrete minor bands (Fig. 1).  Gels 
containing 30-50 t~g of CEA showed very slight diffuse staining with Coomassie 
brilliant blue in the  region of  the periodic acid-Schiff stain. No  staining was 
detectable on these gels with amido schwarz or aniline blue black. The ineffec- 
FIG. 1.  Acrylamide gel electrophoresis of Be CEA preparations. The gel at the left con- 
mined 8 ~ urea and was run at pH 8.9, while the gel at the right contained 0.1% SDS. For 
both gels the sample was 60 #g of CEA and contained 1%/3-mercaptoethanol.  The brom- 
thymol blue tracker dye was marked with India ink (bottom) before staining for periodate 
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tiveness of protein staining of CEA is unexplained; gels containing other pro- 
teins  stained  as  expected.  These findings  suggest that  this  CEA  preparation 
contains  one or more glycoproteins of similar size  and charge characteristics 
and does not contain detectable protein components which, if present,  should 
appear as separate sharp bands in the gels stained for protein. 
The amino acid composition of the Be preparation (Table I) is unremarkable 
except for the absence of methionine.  It should be noted that the composition 
is quite different from that previously reported for CEA (5) but is very similar 
to  the  composition  we have obtained  for  CEA  preparations  from five other 
tumors.  The  amino acid  composition of Na  1-3  is similar to  that of Be,  but 
there  are distinct  differences which  may reflect  the  additional  purification  of 
Na 1-3  (Table I). Protein accounts for 25-50% by weight of the various CEA 
preparations.  The reasons for this wide range in apparent protein content  are 
not clear at the present time. 
Amino  acid  sequence  analysis  of  the  glycoprotein  preparations  were  per- 
formed using an automatic protein sequencer (Beckman 890; Beckman Instru- 
ments, Inc., Fullerton,  Calif.). Phenylthiohydantoin  amino acids were identi- 
fied on a gas chromatograph (Varian  1840;  Varian Aerograph, Walnut Creek, 
Calif.)  (10),  and by conversion to the free amino acid by hydrolysis  with sub- 
sequent identification of the amino acid on the amino acid analyzer (11).  The 
results of sequence analysis are shown in Fig. 2.  16 of the first 19 residues were 
identified  in  the Be preparation.  Be was available only in limited quantities, 
and  the amino acids  at positions  1,  7,  and  15  have not been definitely estab- 
TABLE  I 
Amino Acid Composition of Two CEA Preparations 
Amino acid  Be  Na I-3 
Moles  amino acid/lO 5 g  protein 
Lysine  23.5  28.6 
Histidine  17.2  17.3 
Arginine  33.9  33.5 
Aspartic acid  142.0  124.8 
Threonine  77.6  77.5 
Serine  90.2  91.8 
Glutamic acid  94.5  92.6 
Proline  103.8  100.0 
Glycine  49.0  48.6 
Alanine  54.1  54.7 
Valine  65.6  58.4 
Methionine  < 1.0  < 1.0 
Isoleucine  45.6  41.5 
Leucine  82.3  77.5 
Tyrosine  36.9  34.2 
Phenylalanine  22.4  28.9 
Cystine and cysteine  Not determined  Not determined TERRY,  I-IENKART,  COLIGAN,  AND  TODD  203 
5  10 
Be  ( * )  Leu  Thr  Ile  Glx  +  Ser  ( * )  Pro  Phe  Asx  + 
Na 1-3  Lys  Leu  Thr  Ile  Glu  Ser  Thr  Pro  ]?he  Ash 
15  20 
Be  Val  Ala  Glx  +  Gly  ( * )  Glx  +  Val  Leu  Leu 
Na 1-3  Val  Ala  Glu  Gly  Lys  Glu  Val  Leu  Leu  Leu 
24 
Na 1-3  Val  His  Asn  Leu 
FIG.  2.  Amino-terminal sequences of CEA preparations Be and Na  1-3.  Residues were 
identified by  gas chromatography  and  confirmed by  amino  acid  analysis.  (*),  amino  acid 
could not be defined, +, identified only after hydrolysis, therefore dicarboxylic acids cannot 
be distinguished from amide forms. 
lished. The sequence of Na 1-3 was determined for 24 positions (Fig. 2)  and 
was shown to be identical to that of Be. In addition, however, it was possible 
to establish that the residues at positions 1 and 15 were lysine, that at position 
7 was threonine, and to establish unequivocally the residues at positions 5, 10, 
13, and 16. 
Interpretation  of the  sequence  analysis  depends  upon  the  yield of  amino 
acid in one of the first few positions. The first amino acid, lysine, is not recov- 
ered quantitatively and therefore yields were calculated for leucine at position 
2. Assuming that CEA has a molecular weight of 200,000,  a protein content of 
50%,  and consists of a single polypeptide chain, the yield for preparation Be 
was 35% of theoretical, and that for Na 1-3 was 70% of theoretical. Yield dif- 
ferences may reflect inherent differences in the two CEA preparations, or may 
be due to the additional purification of Na 1-3. Whatever the explanation, this 
range of yields is consistent with that obtained in our sequencer with other 
homogeneous glycoproteins  (e.g.,  immunoglobulin  heavy  chains).  The  yield 
data indicate that  the polypeptide chain being sequenced accounts for all or 
almost all of the protein with unblocked amino-terminal amino acids in these 
preparations. The single sequence obtained demonstrates that the unblocked 
polypeptide chains are homogeneous for the first 24 residues. Additional studies 
will be required to determine whether these preparations  contain significant 
amounts of protein with blocked amino-terminal residues. 
The finding of identical  sequences in  the  CEA preparations  derived from 
two different tumors suggests that the polypeptide chain being sequenced will 
be a constant constituent of material with CEA activity. It has not, however, 
been proven that the proteins being sequenced are indeed associated with CEA 
activity. It is possible, for example, that these proteins are of the same size and 
have  the  same  electrophoretic characteristics  as  the material  carrying CEA 
activity, but that the activity is associated with a different molecular species. 
Additional  studies  are presently in progress in  an  attempt  to  establish firm 
identity  between  this  protein  and  the  molecules  carrying  CEA  antigenic 
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We  are,  at  the  present  time,  isolating  quantities  of  CEA  glycoprotein  to 
enable  determination  of  the  complete  amino  acid  sequence  of  the  relevant 
protein  when  the  various  problems described  above are  solved.  This  should 
be of great interest,  even  if the  carbohydrate  moiety contains  the  antigenic 
activity, since the structural  information will permit comparisons to be made 
with  other  glycoproteins  extracted  from the  membranes of malignant,  fetal, 
and normal adult cells. 
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